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Abstract
Background
The trafficking of the adenomatous polyposis coli (APC) tumour suppressor protein in
mammalian cells is a perennially controversial topic. Immunostaining evidence for an
actin-associated APC localisation at intercellular junctions has been previously
presented, though live imaging of mammalian junctional APC has not been
documented.
Results
Using live imaging of transfected COS-7 cells we observed intercellular junction-
associated pools of GFP-APC in addition to previously documented microtubule-
associated GFP-APC and a variety of minor localisations. Although both microtubule
and junction-associated populations could co-exist within individual cells, they
differed in their subcellular location, dynamic behaviour and sensitivity to cytoskeletal
poisons. GFP-APC deletion mutant analysis indicated that a protein truncated
immediately after the APC armadillo repeat domain retained the ability to localise to
adhesive membranes in transfected cells. Supporting this, we also observed
junctional APC immunostaining in cultures of human colorectal cancer cell line that
express truncated forms of APC.
Conclusions
Our data indicate that APC can be found in two spatially separate populations at the
cell periphery and these populations can co-exist in the same cell. The first
localisation is highly dynamic and associated with microtubules near free edges and
in cell vertices, while the second is comparatively static and is closely associated with
actin at sites of cell-cell contact. Our imaging confirms that human GFP-APC
possesses many of the localisations and behaviours previously seen by live imaging
of Xenopus GFP-APC. However, we report the novel finding that GFP-APC puncta
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can remain associated with the ends of shrinking microtubules. Deletion analysis
indicated that the N-terminal region of the APC protein mediated its junctional
localisation, consistent with our observation that truncated APC proteins in colon
cancer cell lines are still capable of localising to the cell cortex. This may have
implications for the development of colorectal cancer.
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Background
The APC protein plays a pivotal role in WNT signal transduction, has been suggested
to have important functions in cell migration and mitosis, and APC mutation is a
crucial early event in the development of most colorectal cancers [1]. The intracellular
localization of APC has long been the subject of close scrutiny, with a number of
distributions having been described in a variety of experimental systems (for a recent
review see [2]). Two mammalian APC distributions have previously been described
as populations found at peripheral cellular sites. The first of these to be identified and
widely accepted consists of APC clusters that localize to specific cortical sites in a
microtubule-dependent manner [3-5]. Support for this distribution has been presented
in studies examining the behavior of Xenopus APC-GFP fusion proteins in living cells
[6]. In addition, an analogous localization to the plus-ends of microtubules close to
the basolateral surface of highly polarized epithelial cells has been shown [7].
Evidence for a second peripheral pool of APC in the form of an actin-dependent
localization to membranes involved in cell-cell adhesion has been found by
immunostaining studies [3, 5] although the validity of this has been questioned [7].
Nevertheless, evidence that potentially supports a functional role for APC at cell
junctions has recently been presented. In human cells, restoration of expression of
full-length APC in a colorectal cancer cell line has been shown to promote cell-cell
adhesion [8] while in Drosophila the APC homologue E-APC has been shown to
associate with and play a role in maintaining the integrity of epithelial cell junctions, a
localization mediated by its armadillo repeats [9].
To date the great majority of information about the distribution of full-length
mammalian APC has been based upon immunostaining studies in fixed cells. Since
recent work has raised questions about APC antibody specificity [10], confirmation of
these different APC distributions by other means is clearly desirable. While some
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data on GFP-APC expression in COS-7 cells has been previously published [11], this
work concentrated on a purely microtubule-associated GFP-APC localization in
subconfluent populations of cells and the GFP-APC construct used in the study
lacked the N-terminal region of the protein. At present the dynamic behavior of a
junctional APC population in live mammalian cells, if such a population exists, has
not been addressed.
In this study we investigated the intracellular distribution of APC using live
imaging of human GFP-APC fusion proteins in mammalian cells. Our study confirms
previous work showing that GFP-APC can be localized within the cell in a
microtubule-dependent and highly dynamic manner. However, we show for the first
time that human GFP-APC can remain associated with shrinking as well as growing
microtubule tips. We also confirm that human GFP-APC is localized to sites of cell-
cell adhesion in an actin-dependent way in confluent populations of cells. To our
knowledge this is the first time that this actin associated GFP-APC population has
been imaged in living mammalian cells.
Results
Direct observation of microtubule and cell junction associated GFP-APC in
living cells.
To date, a junctional association for mammalian APC has only been observed using
immunofluorescence microscopy. Immunostaining studies of APC distribution are
open to criticisms concerning antibody specificity and fixation artefacts and are
unable to yield data about the dynamic behaviour of the protein. Previous attempts to
examine this localisation using GFP fusion proteins were hampered by the toxic side
effects associated with the expression of full-length APC in mammalian cells [5]. To
address this issue and to further define the subcellular distribution of APC we
attempted to examine the distribution of a GFP-APC fusion protein in a variety of
mammalian cell lines. In most of these transfection efficiencies were low and GFP-
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APC expression was poorly tolerated. However, our data indicated that COS-7 cells
represented a system in which good transfection efficiencies could be achieved and
expression levels suitable for imaging were tolerated without obvious short-term
effects upon cell morphology or viability. However, since COS-7 cells are not
epithelial in origin, we first confirmed that they expressed APC (Figure 2, panel A)
and that the endogenous APC in confluent COS-7 cells was localised to the cell
cortex along with the known junctional proteins cadherin (Figure 3, panels A-C), β-
catenin (Figure 3, panels D-F), and actin (Figure 3, panels G-I). COS-7 cells were
found to possess full-length APC protein and this endogenous APC was found to be
closely associated with junctional proteins, confirming that these cells do indeed form
junctions when confluent. We were therefore confident that we could use this cell line
to study dynamic microtubule-associated, as well as junction-associated localisations
of our GFP-APC constructs. The integrity of GFP-APC constructs used for
localisation studies in COS-7 were confirmed by immunoprecipitation, SDS-PAGE
and Western blotting of transfected cell extracts (Figure 2, panel B+C). The largest of
these fusion proteins (Figure 2, panel B, lanes 1-3), consisting of full-length GFP-
APC and minimal deletion mutants, are indistinguishable by band locations on
Western blots with the gel and blotting systems used in this study because of their
large size.
A variety of GFP-APC distributions could be observed in COS-7 cells using
time-lapse fluorescence microscopy, all consistent with either previous
immunostaining studies or known interactions of mammalian APC, suggesting that
our GFP-APC imaging was a good reflection of endogenous APC behaviour. The first
was an association with microtubule tips at specific regions near the cell periphery
(Figure 4, panel A (arrowheads); additional file 1). This consisted of labelling of
microtubule distal segments and the presence of discrete GFP-APC puncta or
clusters on or just behind the microtubule tip. Cells expressing GFP-APC were co-
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stained with anti-α-tubulin, confirming that the GFP-APC clusters were indeed
microtubule associated (Figure 4, panels B-D). GFP-APC puncta on the end of these
microtubules were observed to move at speeds consistent with microtubule growth
(18±8.4µm/min; n=28 puncta from 3 cells where movement could be continuously
observed for at least 12s). As previously shown by workers using Xenopus GFP-
APC, GFP-APC puncta located behind the microtubule tip underwent anterograde
movement towards the tip [6]. Peripheral deposition of GFP-APC puncta by shrinking
microtubules could also be observed (Figure 4, panels E-H; additional file 2). These
observations closely resembled both previous reports of APC distribution based upon
immunostaining (e.g. [3-5] and the APC-GFP distribution and behaviours described
in Xenopus cells [6]).
However, we noted in COS-7 cells that peripheral GFP-APC puncta on
microtubule ends frequently underwent retrograde linear movements with average
velocities of 21.6±2.4µm/min (Figure 4, panels I-L (arrowhead); additional file 3).
Typically this movement occurred over distances of less than 10µM. In some cases
portions of an original puncta were deposited within the cytoplasm while the
remainder continued retrograde movement on the microtubule end (Figure 4, panels
M-P arrowheads; additional file 4, examples also apparent in additional file 3). We
also noted that the depolymerising microtubules tipped by GFP-APC puncta could
undergo pause and then re-growth with the puncta of GFP-APC still attached (Figure
4, panels Q-T arrowhead; additional file 5). Interestingly, close examination of
sequences such as additional file 5 indicates that separate GFP-APC puncta
decorating the distal segment of a microtubule are swept up into a single tip-
associated structure as the microtubule shrinks but re-separate into a string of
beads-like distribution during microtubule regrowth, before finally beginning to re-
coalesce into a single structure at the tip of paused microtubules near the cell
membrane. The behaviour of GFP-APC at microtubule distal tips is clearly therefore
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very complex. Retrograde trafficking of GFP-APC was not documented in previous
studies [6, 11]. Furthermore, these movements seem likely to represent puncta
associated with shrinking microtubule tips and not with growing tips looping back
from the cell edge or retrograde transport of GFP-APC puncta along microtubules
since the microtubule distal segment could clearly be identified by GFP-APC labelling
in many cases. We therefore conclude that mammalian APC can remain associated
with shrinking microtubule tips at the cell periphery, a novel observation for this
protein.
These observations represented the major GFP-APC distribution in cells
imaged in subconfluent cultures although other minor localisations were also seen.
GFP-APC was occasionally observed at structures resembling the centrosome
(Figure 5, panel A, arrowhead). This localisation was confirmed in fixed COS-7 cells
expressing GFP-APC co-stained with γ-tubulin (Figure 5, panels B-D). A centrosomal
localisation for APC was recently examined in detail by other investigators [12]. In
less than 5% of cells a motile comet-like distribution within the cell interior was seen
(Figure 5, panel E; additional file 6). These comets moved with an average velocity of
20.4±6µm/min (n=29 comets from 3 cells where movement could be tracked for at
least 12s). This was essentially indistinguishable from the distribution and behaviour
observed for the microtubule tip-tracking APC ligands EB1 and EB3 when expressed
as GFP fusion proteins in COS-7 cells (JMA, unpublished data). GFP-APC
expressing COS-7 cells fixed and co-stained for EB1 showed that the GFP-APC
comets did indeed co-localise with EB1 staining at the end of microtubules (Figure 5,
panels F-H). Finally, GFP-APC puncta were occasionally observed in the cell interior
(Figure 5, panel I-L; additional 7). Over the time course of imaging these were either
immobile or underwent rapid translocations at peak speeds consistent with
microtubule motor-mediated transport (in the region of 2-3µm/s). Previous reports
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have described an interaction between APC and kinesin-associated transport
complexes [13] that could explain this behaviour.
In cultures that were seeded and transfected to be largely confluent during
imaging a further GFP-APC distribution was seen. This consisted of a discontinuous
array of punctate structures associated with peripheral membranes contacting other
cells (Figure 6, panel A; additional file 8). This junctional localisation was confirmed
by co-immunostaining for β-catenin (Figure 6, panels B-D) and actin (Figure 6,
panels E-G), both of which confirmed that GFP-APC was closely associated (but not
co-localised) with junctional proteins at the cortex. In comparison with the
microtubule-associated GFP-APC distributions these cortical structures were far less
dynamic. Tracking analysis indicated that they moved with an average velocity of
0.3±0.36µm/min (n=70 puncta from 4 cells continuously observed for at least 10min).
This movement appeared to directly correlate with remodelling of the cell periphery
during long-term changes in cell shape, indicating that these structures were
essentially immobile relative to the cell cortex.
The junctional GFP-APC localisation was dominant in cells having extensive
contacts with neighbouring cells, particularly those in densely confluent regions of an
imaging dish. However, in regions of lower cell density we observed that both the
microtubule and cell junction-associated GFP-APC distributions could be found in
different regions of the same cell (Figure 6, panel H; additional file 9). The junctional
population seen in these cells was unlikely to represent an overexpression artefact
since it was present at low GFP-APC fluorescence intensities and no phenomena
indicative of APC overexpression were seen (for example, GFP-APC decorated
microtubule bundles). Observation of cells with both junctional- and microtubule-
associated GFP-APC confirmed the very different dynamic behaviours of these
protein populations. The microtubule-associated GFP-APC localisation was restricted
to free cell edges and cell vertices and was highly motile whereas the junctional
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localisation was only present at sites of cell-cell contact and was essentially
immobile. Dynamic GFP-APC microtubule-associated clusters were not seen in the
vicinity of cell junctions, although when present the EB1-like localisation to growing
microtubule distal tips was. We therefore suggest that the two GFP-APC populations
might reflect the localised regulation of APC interactions in specific cellular regions.
Previous reports have shown that microtubules can be resistant to
Nocodazole treatment in cells overexpressing microtubule-associated GFP-APC [14].
In order to test the effect of Nocodazole on transfected COS-7 cells possessing
cortical and microtubule-associated GFP-APC we first incubated cells with 5µg/ml
Nocodazole for 1 hour (Figure 7, panels A-C). We noted that even after a one-hour
incubation cells containing a small number of stable microtubules could be found
(Figure 7, panel B, arrows). In transfected cells these remnant microtubules were
decorated with GFP-APC (Figure 7, panels A-C). However, cortical APC could be
clearly distinguished at the cell cortex in the absence of microtubules and appeared
unaffected by Nocodazole treatment (Figure 7, panels A-C, arrowheads). We next
examined the effects of microtubule depolymerisation on GFP-APC-cortical
localisations in living cells. Figure 7, panels D-G and additional file 10 shows a cell in
which both junctional (Figure 7, panels D-G arrowheads, also see additional file 10)
and microtubule (Figure 7, panels D-G arrow, also see additional file 10) GFP-APC
populations are present. At the beginning of the recording Nocodazole was added to
a final concentration of 5µg/ml. As previously reported by other investigators [6], the
GFP-APC localization to microtubule distal tips was rapidly lost and the cortical
clusters at microtubule ends gradually dispersed. However, the behaviour and
intensity of junctional GFP-APC was unaffected by Nocodazole, even in subsequent
experiments where the drug concentration was raised to 20µg/ml for 30min (data not
shown). We conclude that the junctional association of GFP-APC is independent of
microtubules. We next wanted to study the response of junctional GFP-APC to
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treatment with the actin depolymerising drug Cytochalasin D. Preliminary
experiments with this drug at standard experimental concentrations of 10µg/ml led to
rapid cell rounding (data not shown). This made it impossible to study the effects of
Cytochalasin D on cortical GFP-APC dynamics in these cells. We therefore decided
to use low concentrations (1µg/ml) of drug in order to study the effect of gradual, but
not total, loss of cortical actin in COS-7 cells. Treatment of COS-7 cells expressing a
GFP-actin construct [15] confirmed that at low concentrations Cytochalasin D
perturbed actin integrity at the cell cortex in a stereotypical way. Figure 8, panels A-
D, and additional file 11 show a GFP-actin expressing COS-7 cell treated with 1µg/ml
Cytochalasin D. At the beginning of the experiment the cell possesses a cortical actin
belt around the cell periphery. Over the time course of the experiment this cortical
belt can be seen to weaken and break at points within the cell (Figure 8, panels A-D
arrowheads and additional file 11), These breakages lead to the contraction of the
cortical actin belt along cell edges and the accumulation of actin at cell vertices. We
next examined the results of low-level Cytochalasin D treatment in GFP-APC
expressing cells. The results of a typical experiment are shown in Figure 8, panels E-
H, and additional file 12. The cell of interest in this sequence has both cortical- and
microtubule-associated GFP-APC. The earliest response, beginning around 10min
after drug addition, was a slow contraction of the whole cell; this was followed by
breakage of the cell-cell contacts (Figure 8, panels E-H black arrow, and additional
file 12) and the contraction of the GFP-APC puncta along the cell edge (Figure 8,
panels E-H white arrow indicates direction of contraction, and additional file 12). This
data closely resembled the effects of Cytochalasin D on the junction-associated
cortical actin ribbon in COS-7 cells expressing GFP-actin (Figure 8, panels A-D, and
additional file 11). When confluent GFP-APC expressing COS-7 cells were treated
with 1µg/ml Cytochalasin D for 30min before fixation and staining with phalloidin an
association of GFP-APC with both cytoplasmic actin aggregates (Figure 8, panels I-
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K, arrows) and cortical actin (arrowheads) was seen, confirming that the distribution
of GFP-APC was closely linked to that of actin in these cells. These drug
experiments lead us to conclude that in transfected COS-7 cells two spatially
separate populations of GFP-APC exist at the cell periphery and can co-exist in the
same cell. The first is highly dynamic and associated with microtubules near free
edges and cell vertices, while the second is comparatively static and is closely
associated with actin at sites of cell-cell contact.
Deletion analysis of the APC-cell junction association
To further define the domain in APC responsible for mediating its junctional
localisation we made a number of GFP-APC deletion constructs for analysis in COS-
7 cells. It seemed possible that the junctional localisation of APC cells could be
mediated by an interaction with the junctional protein Discs Large (DLG), a known
ligand of APC [16]. This interaction requires the extreme C-terminus of the APC
molecule. We therefore made a construct, pEGFP-APC∆C (Figure 1, panel B), which
directed the expression of full-length GFP-APC lacking its final 54aa. APC also
dimerises using heptad repeats at the N-terminus of the protein and deletion of the
first 58 amino acids of APC prevents this [17, 18]. Since any construct made by us
might potentially be able to localize to junctions by interacting with endogenous APC,
we therefore made a second construct, pEGFP-APC∆N∆C (Figure 1, panel C). This
directed the expression of GFP-APC lacking both its final 54aa and first 207aa, which
would both abolish DLG binding and prevent dimerisation. Expression of these
constructs in transfected cells was confirmed by western blotting (Figure 2, panel B).
In transfected COS-7 cells examined by time-lapse fluorescence microscopy the
distribution of both of these fusion proteins closely resembled that of full-length GFP-
APC, with the full range of both microtubule associated (not shown) and junctional
APC localisations observed (Figure 9, panels A and B, arrowheads). This indicated
that DLG binding was not required to recruit APC to the cortex in COS-7 cells and
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suggested that APC dimerisation was also unnecessary. A third construct, pEGFP-
APC-C1 (Figure 1, panel D), drives the expression of a protein consisting of the last
170 amino acids of APC fused N-terminally to EGFP and would be predicted to
interact with DLG. It showed a diffuse cytoplasmic localization within transfected cells
(Figure 9, panel C), suggesting that a DLG interaction alone is insufficient for APC
targeting to junctions in COS-7 cells. The final construct we examined, pEGFP-APC-
N (Figure 1, panel E), directed the expression of a GFP-APC molecule truncated just
after its armadillo repeat motifs. This construct showed three distinct localizations
within the cell. The first was to the centrosome (Figure 9, panel D, arrow), confirmed
by co-immunostaining of transfected cells for the centrosomal marker γ-tubulin
(Figure 9, panels E-G). This observation confirms previous studies indicating a
centrosomal localization for truncated APC proteins [19]. The second localization was
to small, sometimes motile puncta within the cytoplasm (Figure 9, panel D; additional
file 13). As noted above, the armadillo repeat region of APC has been shown to
mediate an association with kinesin [13]. This association may potentially mediate
this localization, but confirming this hypothesis was beyond the scope of the present
study. The third localization was to sites of cell-cell contact in a distribution that
resembled that previously seen with the full-length GFP-APC protein (Figure 9, panel
D, arrowheads; additional file 13), confirmed by co-immunostaining for β-catenin
(Figure 9, panels H-J. These data strongly suggest that the APC localization to cell
junctions is mediated by a domain lying within the first 746aa of the protein. Unlike
our longer GFP-APC fusion proteins, GFP-APC-N did not localise in dynamic clusters
or decorate microtubule distal tips in specific regions of the cell periphery, nor did it
localise to growing microtubule ends in the cell interior, consistent with a role for the
APC microtubule and EB protein binding domains in mediating these localisations.
Our data indicated that C-terminally truncated GFP-APC molecules retained
an ability to associate with sites of cell-cell contact in transfected cells. The pEGFP-
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APC-N (Figure 1, panel E) construct used in this study is similar to some of the more
extremely truncated APC proteins expressed in colorectal cancer cells. Our
observations might therefore predict that mutant APC should also localise to sites of
cell-cell adhesion in cancer cells, as long as these cells were capable of assembling
functional intercellular junctions. We therefore looked for colon cancer cell lines
containing similar truncations to our pGFP-APC-N construct. The cell line COLO320
expresses an APC protein truncated at amino acid 811. Unfortunately however, this
cell line displays very poor cell-cell adhesion so it was not possible to look at an APC
junctional localisation in this cell type. We therefore examined the distribution of
endogenous APC in the human colorectal tumour cell lines Caco-2 and SW480.
Caco-2 cells possess one mutant copy of APC and express a protein truncated at
amino acid 1367. These cells form adhesive junctions and although the truncated
APC protein is longer than our minimal construct the question of whether C-terminally
truncated APC proteins could localise to the cortex could still be addressed. The
polyclonal M-APC antibody and the monoclonal antibody ALI12-28 would both be
predicted to recognise the truncated APC protein. Unlike a previous report [5], we
found that truncated APC localized to sites of cell-cell adhesion in Caco-2 cells
following immunostaining with the polyclonal M-APC antibody (Figure 10, panels A-
C) or the monoclonal ALI-12-28 antibody (Figure 10, panels D-F), but not with
monoclonal antibodies specific for the APC C-terminus (Figure 10, panels G-I). Cells
were also co-stained for actin to confirm the presence of adhesive junctions in the
confluent cultures (Figure 10, panels J-L). The colon cancer cell line SW480,
containing an APC protein truncated at amino acid 1338, produced similar results to
those seen with Caco-2 cells (data not shown).
Discussion
In this study we have confirmed that APC can be found at sites of cell-cell contact in
mammalian cells by live imaging of GFP-APC fusion proteins. Recently, other
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workers have presented an examination of GFP-APC dynamic behaviour in
transfected COS-7 cells [11] but did not report findings similar to those presented
here. The reasons for this are unclear. Although the GFP-APC construct used in the
previous study contained a short N-terminal deletion our data indicates that this
would not have precluded the observation of a junctional APC population (Figure 9,
panel B). However, we note that the authors of this previous study were primarily
focused upon defining the behaviour of GFP-APC decorated microtubules at
peripheral sites rather than examining the possibility of a GFP-APC pool at cell
junctions. They may not therefore have examined GFP-APC expressing cells in
confluent cell cultures. Similarly, we are unable to conclusively explain why previous
attempts at mapping the minimal region required for the GFP-APC junctional
localisation were unsuccessful and led to the hypothesis that only full-length APC
could achieve this distribution [5]. We suspect, however, that difficulties similar to
those we experienced in attempting to image GFP-APC in cell types other than COS-
7 were a major contributory factor to this.
In addition to the microtubule-associated GFP-APC localisations found by
other workers we identified an association of GFP-APC puncta with shrinking
microtubule tips in transfected COS-7 cells (Figure 4, panels I-L and panels M-P).
APC is known to promote microtubule stability and assembly both in vitro and in vivo
[20-22] and as such we might have expected it to be found only on polymerising
microtubule tips. The presence of GFP-APC puncta on depolymerising tips would
suggest that additional proteins involved in microtubule dynamics might regulate the
effects of APC on microtubule plus-end dynamics. For example, the presence of a
destabilizing factor on a microtubule tip, such as the kin I kinesin MCAK [23, 24],
might override the normal stabilising ability of APC. However, if the destabilising
factor is inactivated on the microtubule, any tip-associated APC could then re-
promote microtubule stability and growth. That Xenopus APC has recently been
shown to associate with MCAK raises the interesting possibility that APC might form
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part of a microtubule plus-end complex responsible for the general control of
microtubule behaviour in specific regions of the cell periphery [25].
The mechanism by which APC associates with actin at cell junctions remains
unclear. An interaction between APC and the mammalian homologue of the
Drosophila discs large protein has been proposed to be responsible for the
localization of APC to neuronal synapses [16], structures that can be regarded as a
specialised form of cadherin-based cell-cell adhesion. However, we found that this
interaction was not essential for localising APC to sites of cell-cell contact in COS-7
cells although an interaction between APC and DLG at the cortex once both proteins
have been recruited there cannot be ruled out. Instead, our data indicated that a
truncated APC containing only the heptad and armadillo repeat domains of the
protein was capable of localizing to junctions.
We therefore propose that the N-terminal region of the APC protein mediates
its localization to the cortex. We speculate that the armadillo repeat regions of APC
mediate this localisation since we also noted that a larger construct lacking a number
of the heptad repeats remained capable of localising to adhesive membranes (Figure
9, panel B). However, further work needs to be carried out to directly confirm this.
This may be complicated by the observation that a number of potential binding
partners exist for the N-terminal region of APC, particularly the armadillo repeat
domain. These include the kinesin-associated protein KAP3, the Rac effector Asef
and the Cdc42 activator IQGAP1 [13, 26, 27]. Any of these could plausibly mediate
an APC junctional localisation, as could an interaction with an as yet unidentified
binding partner for this region of APC. Notably, the Drosophila E-APC protein has
also been shown to localise to sites of cell-cell adhesion via its armadillo repeats [9].
Mislocalization of E-APC leads to the disruption or impairment of intercellular
adhesion, implicating E-APC in the regulation of cell contacts in Drosophila. In the
light of our study and recent observations by other investigators [8] it seems possible
that APC might play a similar role in mammalian epithelial tissues.
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Our observations of cells where both junctional and microtubule-associated
GFP-APC populations were present indicated that these different pools did not
spatially overlap. The question of how this might be achieved has parallels with a
long-standing problem in APC biology: how is APC targeted to the tips of a subset of
microtubule ends at specific sites at the cell periphery? Recent work from other
investigators has indicated that an APC localisation to microtubule ends near free cell
edges arises from a Cdc42-initiated signalling cascade that results in a local
inhibition of GSK3β activity [28]. Phosphorylation by GSK3β inhibits the microtubule-
binding ability of APC [22]. Therefore, local inhibition of the activity of this enzyme
promotes the association of APC with microtubules in specific cellular regions where
Cdc42 is active. Implicit in this model is the assumption that GSK3β activity
elsewhere in the cell normally suppresses the association of APC with microtubules.
If this model is combined with the observation that APC can localise to cell junctions
when they are available then a plausible mechanism for generating the
compartmentalisation seen in our study can be formulated.
Conclusions
In this study we show that APC is capable to localising to both microtubules and to
junctions within the cell, depending on cellular context. The junctional localisation is
likely to be mediated by the N-terminal region of the APC protein. Consistent with this
we find that colon cancer cell lines expressing truncated APC proteins are also
capable of localising to the cortex in cells having the necessary cell-cell contacts. As
well as losing function within the WNT signalling pathway, it seems possible that
truncated APC proteins might act as dominant-negative mutants in cells that retain a
normal copy of the APC protein, with the mutant copy interfering with the action of
full-length APC molecules at intercellular junctions. This may have direct implications
for the development of colorectal cancer.
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Methods
Cells
COS-7 cells were cultured as described previously [29]. Caco-2 and SW480 cells
were obtained from the Cancer Research UK Cell Line Service at the London
Research Institute, Lincoln’s Inn Fields, UK and cultured according to the instructions
supplied. Incubations with cytoskeletal poisons were performed as described
previously [29]. Nocodazole and Cytochalasin D were obtained from Sigma.
Antibodies
The rabbit polyclonal anti M-APC antibody [3] was a kind gift from Dr Inke Näthke,
(University of Dundee), and was used at a 1/500 dilution for immunostaining. The
monoclonal APC antibody ALI 12-28 used in this study was obtained from Cancer
Research UK Antibody Service at the London Research Institute and was used at a
1/500 dilution for immunostaining. It has also been made commercially available by
Abcam and this antibody was used for Westerns at 1/5000 dilution. Rabbit polyclonal
and mouse monoclonal anti-GFP antibodies were obtained from Clontech and used
at a 1/1000 dilution for immunostaining and a 1/2000 dilution for Western Blotting.
Rabbit polyclonal α-catenin, mouse monoclonal β-catenin, rabbit polyclonal pan-
cadherin and mouse monoclonal β-actin antibodies were all obtained from Sigma. All
secondary antibodies were Alexa 488 and 594 conjugates obtained from Molecular
Probes, as was Alexa 594 conjugated phalloidin.
Western Blotting
For Western blotting, cells were resuspended in RIPA buffer (50mM Tris pH7.5,
150mM NaCl, 1% (v/v) Igepal, 0.5% (v/v) Sodium Deoxycholate, 1mM EDTA, 0.1%
(v/v) SDS) buffer containing EDTA free complete protease inhibitors (Roche) and
phosphastase inhibitors cocktail II (Sigma). Protein concentrations for the cell
extracts was determined using a protein assay kit (Pierce). NuPageTM Loading Buffer
(Invitrogen) was then added to 10-20µg of protein extract following the manufacturers
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instructions. Proteins were then separated by SDS-PAGE using a 3-8% Tris-Acetate
NuPageTM gradient gel system (Invitrogen). Proteins were transferred onto
nitrocellulose membranes using NuPageTM transfer buffer as per manufacturers
instructions (Invitrogen). After transfer the nitrocellulose membranes were incubated
in 3% (w/v) BSA/PBS/0.1% (w/v) Tween 20 for 1 hour at room temperature.
Membranes were then incubated overnight at 4°C with the specific antibody diluted in
3% (w/v) BSA/PBS/0.1% (w/v) Tween 20. After washes in PBS/0.1% Tween 20,
membranes were incubated with an HRP-conjugated secondary antibody for 2h
before further extensive washing. Immunoreactivity was detected using the
SuperSignal® West Pico Chemiluminescent Substrate Kit (Pierce).
Immunoprecipitation
For immunoprecipitation, COS-7 cells were transfected as described below (see Live
Imaging) then resuspended in modified RIPA buffer (50mM Tris pH7.4, 80mM KCl,
10mM EDTA, 1% Triton X-100 containing EDTA-free complete protease inhibitors
(Roche) and phosphastase inhibitors cocktail II (Sigma)). Extracts were then
immunoprecipitated with 2µg of polyclonal anti-GFP antibody (Clontech) overnight at
4°C. The following day 40µl of an 80% protein-G sepharose/PBS solution was added
to each extract and incubated for a further 3 hours at 4°C. Extracts were then
washed x3 in modified RIPA buffer and the pellets resuspended in 30µl PBS.
Extracts were then processed for SDS-PAGE and Western blotting as described
previously.
Immunofluorescence
Cells were cultured on sterile coverglasses, processed for immunocytochemistry
using cold methanol [29] or paraformaldehyde fixation [30] and imaged using the
CCD camera based system described below in conjunction with excitation/emission
filtersets for DAPI, FITC and TRITC.
 - 20 -
Live Imaging
Cells were grown and transfected in 35mm glass-bottomed culture dishes (Iwaki
brand; Asahi Techno Glass Corporation, Japan) obtained from Bibby Sterilin.
Transfections were performed using GeneJuice (Novagen) according to the
manufacturers instructions. 12-18h after transfection the standard cell culture
medium was replaced by 2ml of pre-warmed medium supplemented with 20mM
HEPES. The cells were transferred to a Zeiss Axiovert 200 inverted microscope with
a heated chamber enclosing the microscope stage (Solent Scientific, UK) allowing
the temperature to be maintained at 37°C throughout imaging. Cells were imaged by
fluorescence microscopy using a Zeiss Plan Apo 63X/1.4NA oil immersion lens.
Time-lapse images were captured at 3-10s intervals for durations of 5-10min using
Ludl shutters and a Hamamatsu Orca II ER camera. Images were obtained using 2x2
binning with exposure times of less than 350ms/frame. An excitation/emission
filterset optimised for EGFP imaging was used (Chroma Technology Corp.,
Brattleboro, USA; filterset ID 86007). Microscope, camera, filterwheels and shutters
were controlled by Kinetic Imaging AQM 6 software (Kinetic Imaging, Nottingham,
UK). Cells expressing as low a level of fusion protein as could be successfully
imaged using our CCD camera were used in this work. Brightly fluorescent cells,
typically those clearly visible without the use of the camera, often displayed evidence
of extensive microtubule bundling and were excluded from the study. Time-lapse
image series were saved as uncompressed AVI files then cropped, compressed and
converted into Quicktime movies using Adobe ImageReady CS. Tracking analyses
were performed on unprocessed data files using Motion Analysis software from
Kinetic Imaging.
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Expression constructs
The pEGFP-APC plasmid used in this study was a kind gift from Dr. J. Victor Small
(Salzburg, Austria). It directs the expression of full length human APC (2843aa) N-
terminally tagged with the fluorescent protein eGFP. This construct was subjected to
a range of restriction digests and sequencing to confirm its identity. This indicated
that the plasmid directs the expression of a full-length GFP-APC protein (Figure 1,
panel A) similar to that previously described [31] rather than a N-terminally truncated
protein as recently used by other workers [11]. A further four constructs were
produced by restriction enzyme digestion of this plasmid. The first of these, pEGFP-
APC∆C, was obtained by digestion of pEGFP-APC with BspEI and AvrII, resulting in
an APC fragment lacking its final 54 amino acids. This fragment was ligated into
pEGFP-C1 (Clontech) digested with KpnI and XbaI (Figure 1, panel B). A second
construct, pEGFP-APC∆N∆C, was obtained by digestion of pEGFP-APC with KpnI
and AvrII. This results in the removal of the first 206 amino acids from the N-terminus
of APC in addition to the removal of the last 54 amino acids. This product was cloned
into pEGFP-C1 digested with BspEI and XbaI (Figure 1, panel C). The third
construct, pEGFP-APC-C, was created by PCR amplification of a C-terminal APC
fragment using the following primers to obtain the last 170 amino acids of APC:
GFPC1For – 5’CCTAGATCTTCCGGATCTCCCACAG3’
GFPC1Rev –5’TTAGTTTCATGGTACCTCTCTTTTA3’
The forward primer contains a BspEI restriction site and the reverse primer a KpnI
restriction site to allow subcloning of the PCR product into pEGFP-C1 digested with
the same enzymes (Figure 1, panel D). A fourth construct, pEGFP-APC-N, was
obtained by digesting pEGFP-APC with BspEI and HindIIII and cloning the resulting
product into pEGFP-C1. The resulting plasmid directs the expression of the first 746
amino acids of APC N-terminally fused to EGFP (Figure 1, panel E).
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Figures
Figure 1: Schematic of full-length and deletion GFP-APC constructs used in
this study (not to scale).
Panel A. Full-length GFP-APC including known APC domains. Panel B. pEGFP-
APC∆C construct lacking the last 54 amino acids of APC. Panel C. pEGFP-
APC∆N+∆C construct lacking the first 206 and last 54 amino acids of APC. Panel D.
pEGFP-APC-C construct consisting of the last 170 amino acids of APC. Panel E.
pEGFP-APC-N consisting of the first 746 amino acids of APC.
Figure 2: Western blotting of endogenous APC and GFP-APC constructs
expressed in COS-7 cells.
Panel A: Western blot of cell extracts from COS-7 (lane 1), HeLa ( lane 2), MDCK
(lane 3), NRK-52E (lane 4) and Caco-2 (lane 5), 10µg total protein was loaded for
each extract and the membrane probed with the ALI 12-28 antibody specific for the
APC N-terminus. Full-length APC (310kDa) can be detected in all cell lines except
CaCo-2 cells that possess a much smaller truncated APC protein (not shown).
Panel B: Western blot of COS-7 cell extracts transfected with plasmids directing the
expression of GFP-APC (lane 1), GFP-APC-∆N (lane 2), GFP-APC-∆N+∆C (lane 3),
and untransfected COS-7 cells (lane 4). Prior to western blotting extracts were
immunoprecipitated with a polyclonal anti-GFP antibody. The immunoprecipitation
from each extract was loaded onto a gradient gel, subjected to SDS-PAGE,
transferred to nitrocellulose and the membrane probed with a polyclonal anti-GFP
antibody.
Panel C: Western blot of the COS-7 cell extract transfected with the plasmid directing
the expression of GFP-APC-N construct (lane 1) or a non-transfected COS-7 cell
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extract (lane 2). 20µg of each protein extract was loaded onto a 10% non-gradient
gel and the membrane probed with a polyclonal anti-GFP antibody.
Figure 3: Junction formation and APC localisation in COS-7 cells.
Panels A-C. COS-7 cells contain cadherins and endogenous APC (arrowheads) at
sites of cell-cell contact, Cadherin green and APC red, panel C is a merged image.
Panels D-F. COS-7 cells also have the junctional protein β-catenin localised along
with endogenous APC (arrowheads) at adhesive membranes. β-catenin green, APC
red and DAPI blue, panel F is a merged image. Panels G-I. Cortical actin and APC
(arrowheads) are associated with sites of cell-cell contact in COS-7 cells. Actin red,
APC green and DAPI blue, Panel I is a merged image. Bars = 10µm.
Figure 4: Detailed imaging of full-length GFP-APC in living COS-7 cells.
Panel A. In subconfluent cells GFP-APC decorates the distal tips of microtubules at
cell vertices (arrows, additional file 1, 5s time lapse). Panels B-D. GFP-APC clusters
decorating distal tips of microtubules in fixed GFP-APC expressing cells. GFP-APC
green, tubulin red and DAPI blue, panel D is a merged image. Panels E-H. GFP-APC
puncta can be deposited at the cell cortex (arrows, additional file 2). Panels I-L. GFP-
APC puncta could be seen undergoing retrograde movements at the cell periphery
(arrowhead, additional file 3). Panels M-P. Part of an original GFP-APC puncta is lost
from a shrinking tip while the remaining attached portion continues retrograde
movement (arrowheads, additional file 4). Panels Q-T. Some shrinking microtubules
tipped with GFP-APC puncta undergo re-growth after periods of shrinkage
(arrowhead, move 5). Bars = 10µm.
Figure 5: Additional localisations seen in GFP-APC expressing COS-7 cells.
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Panel A. In some cells GFP-APC can be seen at the centrosome (arrowhead).
Panels B-D. Localisation of GFP-APC to the centrosome was confirmed in
immunostained cells using the centrosomal marker γ-tubulin. GFP-APC green, γ-
tubulin red, panel D is a merged image. Panel E. A minor population of transfected
cells had a comet-like GFP-APC distribution (additional file 6). Panels F- H. Co-
staining of GFP-APC expressing COS-7 cells with EB1 confirmed the two proteins
co-localise at growing microtubule tips in some cells. GFP-APC green, EB1 red,
Panel H is a merged image. Panels I-L. Occasional cells contained GFP-APC puncta
that were rapidly transported through the cytoplasm (arrowhead, additional file 7).
Bars = 10µm
Figure 6: Localisation of GFP-APC to junctional membranes in COS-7 cells.
Panel A. In highly confluent cells GFP-APC showed a purely junctional localisation
(additional file 8,). Panels B-D. GFP-APC at the cortex in COS-7 cells is located
close to the junctional protein α-catenin. GFP-APC green, α-catenin red, panel D is a
merged image. Panels E-G. GFP-APC is also closely associated with cortical actin at
sites of cell-cell adhesion. GFP-APC green, actin red, Panel G is a merged image.
Panel H. Both junctional (arrowheads) and microtubule-associated (arrow) GFP-APC
populations can co-exist in the same cell (additional file 9). Bars = 10µm.
Figure 7: Effects of microtubule depolymerisation on GFP-APC distribution in
COS-7 cells.
Panels A-C. GFP-APC expressing COS-7 cells were incubated for 60min in 5µg/ml
Nocodazole. GFP-APC associated with remnant microtubules (arrows) can be found
in Nocodazole treated cells. However, junctional GFP-APC (arrowheads) is not
associated with microtubules and appears unaffected by Nocodazole treatment.
GFP-APC green, tubulin red, panel C is a merged image. Panels D-G. Nocodazole
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treatment of living cells possessing microtubule-associated and junctional-associated
GFP-APC (additional file 10). Microtubule-associated GFP-APC (arrow) disperses
over time but junctional GFP-APC puncta (arrowheads) are unaffected.
Figure 8: Effect of actin poison on GFP-APC localisation in COS-7 cells.
Panels A-D. Treatment of GFP-actin expressing COS-7 cells with 1µg/ml
Cytochalasin D gradually perturbed the integrity of the cortical actin ribbon. With
increasing time of exposure to drug the cortical actin ribbon thins, snaps and
contracts (arrowheads, additional file 11 arrows). Bars = 20µm. Panels E-H.
Cytochalasin D treatment (1µg/ml) of cells possessing both microtubule-associated
and junctional GFP-APC (additional file 12). Following drug addition cell-cell contacts
decorated with GFP-APC puncta can be seen to break (black arrow), followed by
movement of the GFP-APC puncta along the cell edge towards cell vertices (white
arrow shows direction of movement). The dynamic behaviour of microtubule-
associated GFP-APC continues within the constraints imposed by retraction of the
free cell edge. Bars = 10µm. Panels I-K. Paraformaldehyde fixed, phalloidin-stained
cells expressing GFP-APC after 30min treatment with Cytochalasin D (1µg/ml). Co-
localization of GFP-APC with actin aggregates in the cytoplasm (arrows) and with
cortical actin (arrowheads) is seen. GFP green, phalloidin red, panel K is a merged
image. Bars = 20µm.
Figure 9: Distribution of truncated APC proteins.
Panels A and B. GFP-APC∆C and GFP-APC∆N∆C localize to both the cortex
(arrowheads) and to microtubules (data not shown) in a manner similar to that
previously seen for GFP-APC. Panel C. The short C-terminal fragment GFP-APC-C1
has a cytoplasmic localization similar to that seen with GFP alone (data not shown).
Panel D. GFP-APC-N localizes to the centrosome (arrow), cytoplasmic puncta and
 - 30 -
the cortex (arrowheads, additional file 13). Panels E-G. GFP-APC-N expressing cells
co-immunostained for the centrosomal marker γ-tubulin show GFP-APC-N localises
to the centrosome (arrow). GFP-APC-N green, γ-tubulin red, panel G is a merged
image. Panels H-J. GFP-APC-N expressing cells co-immunostained for β-catenin
confirm the GFP-APC-N junctional localisation (arrowheads). GFP-APC-N green, β-
catenin red. Panel J is a merged image. Bars = 10µm.
Figure 10: Junctional staining of the colon cancer cell line Caco-2.
Panels A-C. Confluent Caco-2 cells were co-immunostained with the polyclonal M-
APC antibody and for microtubules. A microtubule-independent junctional localisation
is seen. Tubulin green, APC red and DAPI blue. Panel C is a merged image. Panels
D-F. Confluent Caco-2 cells immunostained using the monoclonal antibody ALI 12-
28. Tubulin red, APC green and DAPI blue. Panel F is a merged image. Panels G-I.
A monoclonal antibody specific for the APC C-terminus shows no specific APC
localisation, as would be expected with the truncated APC expressed in Caco-2 cells.
Tubulin red, APC green and DAPI blue, panel I is a merged image. Panels J-L. Actin
and APC co-staining in Caco-2 cells confirms the localisation of APC to junctional
membranes. Actin green, M-APC red, panel L is a merged image. Bars = 10µm.
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Additional Files
Additional file 1
File format – Quicktime movie
File size – 6437K
Microtubule-dependent localisation of full-length GFP-APC expressed in
subconfluent COS-7 cells. This movie shows a subconfluent cell with GFP-APC
associated with microtubule tips at specific regions near the cell periphery, typically in
cell vertices. Microtubule tip labelling was comprised of discrete GFP-APC puncta or
clusters in conjunction with a dimmer, less specific labelling of microtubule distal
segments. Image capture rate was 1frame/5s using a 63x oil immersion lens. Movie
is played back at 20 frames/s.
Additional file 2
File format – Quicktime movie
File size – 474k
Peripheral deposition of GFP-APC puncta in COS-7 cells. Microtubule-associated
GFP-APC puncta can be deposited at the cell periphery by shrinking microtubules.
Two microtubules can be seen to grow towards the cell periphery depositing GFP-
APC puncta at the cortex (arrowheads). Once the puncta has contacted the cell
periphery the microtubule can be seen to shrink away from the cell edge leaving the
original puncta at the periphery. Close observation of this image sequence suggested
that GFP-APC puncta might remain associated with shrinking microtubule ends; this
is examined in more detail in subsequent movies. Image capture rate was 1 frame/5s
using a 63x oil immersion lens and the movie is played back at 20 frames/s.
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Additional file 3
File format – Quicktime movie
File size – 206K
Retrograde movement of GFP-APC puncta in COS-7 cells. Peripheral GFP-APC
puncta underwent linear retrograde movements with an average velocity of
21.6±2.4µm. An example is indicated in this movie by the arrowhead. These
movements predominantly occurred over short distances of less than 10µm. Image
capture rate was 1 frame/3s using a 63x oil immersion lens. The movie is played
back at 10 frames/s.
Additional file 4
File format – Quicktime movie
File size – 614K
Partial deposition of microtubule-associated GFP-APC puncta in COS-7 cells. The
movie shows a GFP-APC puncta (arrowhead) undergoing retrograde movement on a
shrinking microtubule end within the cytoplasm. Part of this original puncta is
deposited within the cytoplasm (arrowhead 2) while the remainder continues
retrograde movement (arrowhead 1). Note that close examination of additional files 2
and 3 reveal similar behaviours. Image capture rate was 1 frame/5s using a 63x oil
immersion lens. The movie is played back at 10 frames/s.
Additional file 5
File format – Quicktime movie
File size – 914K
Microtubules possessing GFP-APC puncta could be seen to undergo shrinkage
followed by a period of pause and then growth (arrowhead). GFP-APC puncta
remained at the end of the microtubule throughout this cycle of shrinkage and
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growth. Of interest in this sequence is the observation that separate microtubule-
associated GFP-APC puncta coalesce into a single large structure at the microtubule
tip during shrinkage, then separate out into a distribution resembling beads on a
string during microtubule regrowth, before beginning to re-coalesce on the paused
microtubule tip at the cell periphery. Image capture was 1 frame/5s using a 63x oil
immersion lens, the movie is played back at 10 frames/s.
Additional file 6
File format – Quicktime movie
File size – 4067K
Comet-like GFP-APC expression in COS-7 cells. Occasionally cells were found with
a motile comet-like distribution within the cell interior. These comets moved with an
average velocity of 20.4±6µm/min, essentially indistinguishable from the distribution
and behaviour observed for the microtubule tip-tracking APC ligands EB1 and EB3
when expressed as GFP fusion proteins in COS-7 cells. Image capture rate was 1
frame/3s using a 63x oil immersion lens and movie is played back at 20 frames/s.
Additional file 7
File format – Quicktime movie
File size – 1187K
Fast moving GFP-APC puncta within the cytoplasm of COS-7 cells. GFP-APC puncta
were occasionally observed undergoing rapid transport within the cell interior at
velocities in the region of 2µm/s, speeds consistent with microtubule motor-mediated
transport. Microtubule and junction-associated GFP-APC populations are also visible
at the cell periphery in this sequence. Image capture rate was 1 frame/3s using a 63x
oil immersion lens and movie is played back at 20 frames/s.
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Additional file 8
File format – Quicktime movie
File size – 4750K
Cortically-localised GFP-APC in COS-7 cells. In confluent cultures of transfected
COS-7 cells GFP-APC was present as a discontinuous array of punctate structures
associated with membranes contacting adjacent cells. These puncta were far less
dynamic than microtubule-associated GFP-APC distributions, being essentially
immobile relative to the cell cortex. Image capture rate was 1 frame/10s using a 63x
oil immersion lens and movie is played back at 20 frames/s.
Additional file 9
File format – Quicktime movie
File size – 4365K
Regional specificity of different GFP-APC localisations in COS-7 cells. In partially
confluent COS-7 cells having both contacted and free edges, microtubule and
junction-associated GFP-APC populations exist in the same cell but never overlap.
Image capture was rate 1 frame/5s using a 63x oil immersion lens and movie is
played back at 20 frames/s.
Additional file 10
File format – Quicktime movie
File size – 5172K
Live imaging of Nocodazole treated COS-7 cell expressing GFP-APC. This movie
shows a cell with junction-associated GFP-APC (arrowheads) and microtubule-
associated GFP-APC (arrow). After addition of Nocodazole to a final concentration of
5µg/ml the microtubule-associated GFP-APC population is rapidly lost whereas the
junction-associated GFP-APC is largely unaffected. Image capture rate was 1
frame/10s and movie played back at 20 frames/s.
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Additional file 11
File format – Quicktime movie
File size – 3805K
Live imaging of Cytochalasin D treated COS-7 cell expressing GFP-actin. This movie
shows two cells forming cell-cell contacts. A cortical actin belt can be seen around
the circumference of the cells. Upon addition of 1µg/ml Cytochalasin D the cortical
actin belt is weakened and contracts along the cell edge (arrowheads). Image
capture rate was 1 frame/min, movie played back at 20 frames/s.
Additional file 12
File format – Quicktime movie
File size – 5391K
Live imaging of Cytochalasin D treated COS-7 cell expressing GFP-APC. This movie
shows two GFP-APC expressing cells forming a cell-cell contact. GFP-APC is
present along the cortex at the site of cell-cell contact and on microtubules near a
free edge in the upper cell. Upon addition of Cytochalasin D the cell-cell contact
between the cells is weakened and undergoes breakage (black arrow). The cortical
GFP-APC puncta are then seen to contract towards the cell vertices in the direction
of the white arrow. The microtubule-associated GFP-APC appears unaffected by
Cytochalasin D treatment, within the constraints imposed by retraction of the cell
edge. Image capture rate was 1 frame/min, movie played back at 20 frames/s.
Additional file 13
File format – Quicktime movie
File size – 4486K
Expression of pEGFP-N construct in COS-7 cells. Expression of the short N-terminal
APC construct led to the identification of 3 distinct localisations. The first was to the
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centrosome (arrow), the second to small, sometimes motile puncta within the
cytoplasm, and the final localisation was to sites of cell-cell adhesion (arrowheads).
Image capture rate was 1 frame/10s using a 63x oil immersion lens and the movie is
played back at 20 frames/s.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9
Figure 10
Additional files provided with this submission:
Additional file 13 : Movie 13.mov : 4486Kb
http://www.biomedcentral.com/imedia/1343960822766389/sup13.MOV
Additional file 12 : Movie 12.mov : 5391Kb
http://www.biomedcentral.com/imedia/1134790792766389/sup12.MOV
Additional file 11 : Movie 11.mov : 3805Kb
http://www.biomedcentral.com/imedia/4233147557663896/sup11.MOV
Additional file 10 : Movie 10.mov : 5172Kb
http://www.biomedcentral.com/imedia/1325569931766389/sup10.MOV
Additional file 9 : Movie 9.mov : 4365Kb
http://www.biomedcentral.com/imedia/2118443502766389/sup9.MOV
Additional file 8 : Movie 8.mov : 4750Kb
http://www.biomedcentral.com/imedia/2003607551766389/sup8.MOV
Additional file 7 : Movie 7.mov : 1187Kb
http://www.biomedcentral.com/imedia/2714069327663896/sup7.MOV
Additional file 6 : Movie 6.mov : 4067Kb
http://www.biomedcentral.com/imedia/8944792917663896/sup6.MOV
Additional file 5 : Movie 5.mov : 914Kb
http://www.biomedcentral.com/imedia/1527831870766389/sup5.MOV
Additional file 4 : Movie 4.mov : 614Kb
http://www.biomedcentral.com/imedia/1321382655766389/sup4.MOV
Additional file 3 : Movie 3.mov : 206Kb
http://www.biomedcentral.com/imedia/9649674287663896/sup3.MOV
Additional file 2 : Movie 2.mov : 474Kb
http://www.biomedcentral.com/imedia/9239490037663896/sup2.MOV
Additional file 1 : Movie 1.mov : 6437Kb
http://www.biomedcentral.com/imedia/1828495127663895/sup1.MOV
